Short Message System (SMS) for Caregivers of Suicidal Patients to Prevent Recidivism of Suicide Attempts (C-SIAM)

November 26, 2025 updated by: University Hospital, Brest
Assessment of the feasibility of a monitoring device by SMS in which messages are sent by the caregiver after a suicidal act.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Brest, France, 29609
        • CHU de Brest

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Male or female, over 18 years of age and hospitalized;
  • Survivor of a suicide attempt;
  • Giving informed, dated and signed consent;
  • Can be reached by mobile phone. The study is proposed to all adult suicides and to the patient's designated caregiver, meeting the inclusion criteria.

Exclusion Criteria:

  • Patient whose clinical condition is incompatible with the formulation of his non-opposition.
  • The patient and his / her caregiver shall not be afforded a protective justice measure.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SMS
The patients will receive from the caregiver a first SMS 48 hours after their discharge from the hospital then a total of 4 messages : 48 hours, S1, S2, and S4.
Device: SMS
SMS contact from the caregiver with patient after discharge in intervention group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of the feasibility of the device by the patient according to a validated questionnaire
Time Frame: 6 months
The primary endpoint is the measurement of the feasibility of the device by the patient based on a validated questionnaire. This evaluation will take place during the medical interview that will close the study participation.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The questionnaire measuring the feasibility for the caregiver of such a device
Time Frame: 6 months
A questionnaire will be provided to the caregiver to measure the feasibility of such a device
6 months
Questionnaires on the acceptability of patients and caregivers in relation to the use of this type of monitoring device
Time Frame: 6 months
Acceptability questionnaires will be provided to patients and caregivers in relation to the use of this type of monitoring device
6 months
Qualitative analysis of messages sent to patients during the study.
Time Frame: 6 months
A qualitative analysis of the messages addressed to the patients during the study will be carried out.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Brest

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 19, 2017

Primary Completion (Actual)

August 8, 2019

Study Completion (Actual)

August 8, 2019

Study Registration Dates

First Submitted

February 28, 2017

First Submitted That Met QC Criteria

March 2, 2017

First Posted (Actual)

March 3, 2017

Study Record Updates

Last Update Posted (Estimated)

December 3, 2025

Last Update Submitted That Met QC Criteria

November 26, 2025

Last Verified

May 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • C-SIAM (29.BRC.16.115)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe